Eleftherios Pavlos

Aug 28, 2024 | biorxiv.org | Maria Papadaki |Eleftherios Pavlos |Marc Dubourdeau |Vincent Bailif

AbstractSevere COVID-19 is characterized by excessive inflammation leading to the development of pneumonia and acute respiratory distress syndrome. Bioactive lipid mediators (LMs) derived from ω6 and ω3 polyunsaturated fatty acids are central to the regulation of inflammation, controlling both its initiation and resolution. Still, their role in COVID-19 remains underexplored.